VCU Massey Cancer Center

Menu

Clinical news

Translational Research Initiative for Pain and Neuropathy (TRIPN) hosts inaugural research symposium

On Tuesday, November 5, the VCU Translational Research Initiative for Pain and Neuropathy (TRIPN) hosted its inaugural symposium showcasing the latest developments in pain and neuropathy research.

Continue reading →

VCU Massey Cancer Center partners with Children’s Hospital of Richmond at VCU to offer CAR T-cell therapy to children

This summer, VCU Massey Cancer Center in partnership with Children’s Hospital of Richmond at VCU (CHoR) became a certified treatment center for Novartis’ KYMRIAH, an FDA-approved CAR T-cell therapy for acute lymphoblastic leukemia in children and young adults. Massey was the first in Virginia to offer an FDA-approved CAR T-cell therapy last year with Gilead’s YESCARTA, and the addition of KYMRIAH is another milestone in providing expanded access to cutting-edge cellular immunotherapies.

Continue reading →

Portrait of Dr. Kandace Mcguire

Q&A with Dr. Kandace McGuire on new mammography guidelines from The American Society of Breast Surgeons

This week, The American Society of Breast Surgeons (ASBrS) issued new mammogram guidelines that recommend women of average risk of breast cancer should begin annual screening mammograms starting at age 40 and that women over 25 should undergo a formal risk assessment for breast cancer. Kandace McGuire, M.D., chief of breast surgery and director of the Breast Cancer Collaborative Care Clinic at VCU Massey Cancer Center, supports these new guidelines even though they differ from those suggested by the US Preventive Services Task Force (USPSTF) and the American Cancer Society (ACS). 

In this Q&A, Dr. McGuire discusses the new guidelines and the reasons she supports them.

Continue reading →

New therapy for blood cancers developed

Clinical researchers at VCU Massey Cancer Center have successfully completed a phase 1 clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a phase 2 clinical trial to test the safety and effectiveness of the new therapy.

Continue reading →

Massey Physicians named Richmond Magazine’s Top Docs 2016

VCU Massey Cancer Center physicians again were recognized in Richmond Magazine’s annual list of “Top Docs.” Featured in the magazine’s April 2016 issue, the list includes 31 doctors from varied specialties who provide oncology-related care to Massey’s patients, including 10 who care for pediatric patients at the Children’s Hospital of Richmond at VCU. The selections were the result of a survey that asked Richmond-area physicians who they would recommend in a range of specialties.

Continue reading →